No abstract available
Keywords:
Lymphoproliferative disease; Hemophagocytosis; Epstein-Barr virus.
MeSH terms
-
Biomarkers
-
Combined Modality Therapy
-
DNA Mutational Analysis
-
Fatal Outcome
-
Genetic Association Studies*
-
Genetic Predisposition to Disease*
-
Humans
-
Lymphoproliferative Disorders / diagnosis*
-
Lymphoproliferative Disorders / drug therapy
-
Lymphoproliferative Disorders / genetics*
-
Male
-
Mutation*
-
Pedigree
-
Signaling Lymphocytic Activation Molecule Associated Protein / genetics*
-
Turkey
-
Young Adult
Substances
-
Biomarkers
-
SH2D1A protein, human
-
Signaling Lymphocytic Activation Molecule Associated Protein